1st Quarter - Report — JONES PUBLIC AFFAIRS, INC. for THE SAFDAR GROUP (ON BEHALF OF THE PART… (2011)

Firm

JONES PUBLIC AFFAIRS, INC.

Client

THE SAFDAR GROUP (ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES)

Income

$20,000

Expenses

—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications

Lobbyist	Covered position, as disclosed
DEBORAH DANUSER	Intern for U.S. Senator Kent Conrad
BERNA DIEHL	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Pharmacy PHA

Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications

Lobbyist	Covered position, as disclosed
DEBORAH DANUSER	Intern for U.S. Senator Kent Conrad
BERNA DIEHL	—

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications

Lobbyist	Covered position, as disclosed
DEBORAH DANUSER	Intern for U.S. Senator Kent Conrad
BERNA DIEHL	—

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.